Contineum Therapeutics, Inc. Class A Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 2.12 M | $24.93 M | 100.00% | 8.19% |
| JOHNSON & JOHNSON | 11/13/2025 | 1.98 M | $23.26 M | 0.00% | 7.64% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.72 M | $20.21 M | 0.00% | 6.64% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.66 M | $19.45 M | -2.55% | 6.39% |
| VANGUARD GROUP INC | 11/07/2025 | 964.23 K | $11.33 M | 29.60% | 3.72% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 951.32 K | $11.18 M | 100.00% | 3.67% |
| FMR LLC | 11/13/2025 | 814.87 K | $9.57 M | -3.35% | 3.15% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 800.79 K | $9.41 M | 0.00% | 3.09% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 714.59 K | $8.40 M | 2.16% | 2.76% |
| HHLR ADVISORS, LTD. | 11/14/2025 | 669.34 K | $7.86 M | 0.00% | 2.58% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 646.02 K | $7.59 M | 388.01% | 2.49% |
| RED TREE MANAGEMENT, LLC | 11/07/2025 | 638.16 K | $7.50 M | 0.00% | 2.46% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 571.14 K | $6.71 M | -3.00% | 2.21% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/10/2025 | 542.63 K | $6.38 M | 0.00% | 2.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 367.65 K | $4.32 M | -5.40% | 1.42% |
| BLACKROCK, INC. | 11/12/2025 | 322.03 K | $3.78 M | 94.64% | 1.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 211.05 K | $2.48 M | 195.99% | 0.82% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 204.12 K | $2.40 M | 913.95% | 0.79% |
| MARSHALL WACE, LLP | 11/13/2025 | 193.49 K | $2.27 M | 574.54% | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 166.16 K | $1.95 M | 100.00% | 0.64% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 148.33 K | $1.74 M | 0.00% | 0.57% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 134.62 K | $1.58 M | 100.00% | 0.52% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 110.18 K | $1.29 M | 323.13% | 0.43% |
| MORGAN STANLEY | 11/14/2025 | 93.00 K | $1.09 M | 0.10% | 0.36% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 77.96 K | $916.04 K | -53.26% | 0.30% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 77.67 K | $912.62 K | -75.15% | 0.30% |
| UBS GROUP AG | 11/13/2025 | 68.50 K | $804.92 K | 793.72% | 0.26% |
| STATE STREET CORP | 11/14/2025 | 62.43 K | $733.53 K | 116.01% | 0.24% |
| STRATEGIES WEALTH ADVISORS, LLC | 11/12/2025 | 50.00 K | $587.50 K | 0.00% | 0.19% |
| NORTHERN TRUST CORP | 11/14/2025 | 48.96 K | $575.32 K | 94.54% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 41.58 K | $488.57 K | 116.56% | 0.16% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 41.20 K | $484.10 K | 186.03% | 0.16% |
| RBF CAPITAL, LLC | 11/14/2025 | 40.00 K | $470.00 K | 0.00% | 0.15% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 37.94 K | $445.83 K | -37.76% | 0.15% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 30.14 K | $354.09 K | -50.54% | 0.12% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 29.31 K | $344.39 K | 100.00% | 0.11% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 26.47 K | $308.00 K | 390.19% | 0.10% |
| BAKER ELLIS ASSET MANAGEMENT LLC | 10/23/2025 | 19.50 K | $229.13 K | 100.00% | 0.08% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 19.20 K | $225.60 K | 100.00% | 0.07% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 18.50 K | $217.33 K | -88.73% | 0.07% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 13.09 K | $153.76 K | -85.36% | 0.05% |
| BAILARD, INC. | 10/30/2025 | 12.35 K | $145.11 K | 100.00% | 0.05% |
| MARINER, LLC | 11/14/2025 | 10.42 K | $122.44 K | 100.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 7.24 K | $85.02 K | 500.00% | 0.03% |
| BARCLAYS PLC | 11/12/2025 | 6.48 K | $76.09 K | 273.90% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 5.36 K | $62.97 K | -28.95% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2025 | 2.83 K | $33.00 K | -12.69% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 2.56 K | $30.08 K | 0.00% | 0.01% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2025 | 1.83 K | $21.55 K | -62.14% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.68 K | $19.68 K | -77.53% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Contineum Therapeutics, Inc. Class A Common Stock institutional Ownership - FAQ's
During the previous two years, 86 institutional investors and hedge funds held shares of Contineum Therapeutics, Inc. Class A Common Stock. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 2.12 M
JOHNSON & JOHNSON: 1.98 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 1.72 M
FRANKLIN RESOURCES INC: 1.66 M
VANGUARD GROUP INC: 964,232
BALYASNY ASSET MANAGEMENT L.P.: 951,320
67.49% of Contineum Therapeutics, Inc. Class A Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 18.06 M shares in the last 24 months. This purchase volume represents approximately $198.27 M in transactions.